Wellington Management Group LLP has notified that it crossed the 5% voting rights threshold in Admiral Group PLC as of November 6, 2026. The group holds a total of 5.01% voting rights through direct shares and financial instruments. This disclosure is important for investors as it signals a significant stake and potential influence in the company's decisions. The notification was officially made on November 9, 2026, reflecting Wellington's investment position in Admiral Group.
Wellington Management Group LLP's holding in Admiral Group PLC is noted here as market context. For readers following Financials, of 142 priced US stocks on Pluang, 113 rose and 27 fell today. Notable movers include LU at USD 7.84 with a -16.06% change, PSEC at USD 1.53 with +8.51%, and SAN at USD 12.53 with +6.73%, as of Nov 10, 2026 13:51 WIB.
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...
Pragmatic Semiconductor has appointed Mercedes Johnson as a Non-Executive Director on its Board, effective November 6, 2026. Johnson brings over 40 years of semiconductor industry finance and governance experience, having held senior roles at Broadco...
Equinor ASA has completed the fourth tranche of its 2026 share buyback program, repurchasing a total of 974,300 shares at an average price of NOK 420.35 per share between November 2 and 6, 2026. This brings Equinor's total holdings of its own shares ...
UBS upgraded Morgan Stanley Direct Lending Fund (MSDL) from Neutral to Buy following strong Q3 2026 net investment income of $40.3 million, beating earnings estimates. The fund declared a fourth-quarter dividend and plans fee cuts in 2027 to boost in...
Roche presented new data on its Alzheimer’s disease portfolio at the CTAD 2026 conference, highlighting advances in both pharmaceuticals and diagnostics. Key updates include Phase Ib/IIa data for trontinemab showing rapid amyloid clearance, the start...
